Pulmonx (LUNG) Depreciation & Amortization (CF) (2019 - 2025)
Pulmonx (LUNG) reported Depreciation & Amortization (CF) of $246000.0 for Q3 2025, down 34.57% year-over-year from $376000.0 in Q3 2024, and down 17.73% quarter-over-quarter from $299000.0 in Q2 2025.
Pulmonx (LUNG) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $246000.0 in Q3 2025.
- Depreciation & Amortization (CF) for Q3 2025 came in at $246000.0, down 34.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $823000.0 (down 44.88% YoY), and the FY2024 annual result was $1.5 million, down 3.55% from the prior year.
- Depreciation & Amortization (CF) fell to $246000.0 in Q3 2025 per LUNG's latest filing, from $299000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $437000.0 in Q1 2023 and troughed at $141000.0 in Q1 2021.
- A 5-year average of $328631.6 and a median of $374000.0 in 2021 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2021 and 2025: Depreciation & Amortization (CF) jumped 192.19% in 2021, then slumped 34.57% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $374000.0 in 2021, then advanced by 3.21% to $386000.0 in 2022, then dropped by 25.65% to $287000.0 in 2023, then grew by 2.44% to $294000.0 in 2024, then dropped by 16.33% to $246000.0 in 2025.
- Business Quant data shows LUNG's Depreciation & Amortization (CF) at $246000.0 in Q3 2025, $299000.0 in Q2 2025, and $278000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 246,000.00 |
| Sep 30, 2025 | 246,000.00 |
| Jun 30, 2025 | 299,000.00 |
| Jun 30, 2025 | 299,000.00 |
| Mar 31, 2025 | 278,000.00 |
| Mar 31, 2025 | 278,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 30, 2023 | 415,000.00 |
| Sep 30, 2023 | 415,000.00 |
| Jun 30, 2023 | 409,000.00 |
| Jun 30, 2023 | 409,000.00 |